The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Performance of FDG PET/CT in the Clinical Management of Breast Cancer
Abstract
In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art positron emission tomography (PET)/computed tomography (CT) technology. The strengths and limitations of FDG PET/CT are examined in various clinical settings, and the following questions are answered: Is FDG PET/CT useful to differentiate malignant from benign breast lesions? Can FDG PET/CT replace sentinel node biopsy for axillary staging? What is the role of FDG PET/CT in initial staging of inflammatory or locally advanced breast cancer? What is the role of FDG PET/CT in initial staging of clinical stage IIA and IIB and primary operable stage IIIA breast cancer? How does FDG PET/CT compare with conventional techniques in the restaging of cancer in patients who are suspected of having disease recurrence? What is the role of FDG PET/CT in the assessment of early response to neoadjuvant therapy and of response to therapy for metastatic disease? Some recommendations for clinical practice are given.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
Fisher, B., Bryant, J., Wolmark, N., Mamounas, E., Brown, A., Fisher, E. R., Wickerham, D. L., Begovic, M., DeCillis, A., Robidoux, A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2672 · Cited by 2,165
Rastogi, P., Anderson, S. J., Bear, H. D., Geyer, C. E., Kahlenberg, M. S., Robidoux, A., Margolese, R. G., Hoehn, J. L., Vogel, V. G., Dakhil, S. R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0235 · Cited by 1,789
Young, H., Baum, R., Cremerius, U., Herholz, K., Hoekstra, O., Lammertsma, A. A., Pruim, J., & Price, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00229-4 · Cited by 1,720
Bear, H. D., Anderson, S., Smith, R. E., Geyer, C. E., Mamounas, E. P., Fisher, B., Brown, A. M., Robidoux, A., Margolese, R., Kahlenberg, M. S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.1665 · Cited by 943
Bos, R., van der Hoeven, J. J. M., van der Wall, E., van der Groep, P., van Diest, P. J., Comans, E. F. I., Joshi, U., Semenza, G. L., Hoekstra, O. S., Lammertsma, A. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.379 · Cited by 591
Avril, N., Rosé, C. A., Schelling, M., Dose, J., Kuhn, W., Bense, S., Weber, W., Ziegler, S., Graeff, H., & Schwaiger, M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.20.3495 · Cited by 557
Schelling, M., Avril, N., Nährig, J., Kuhn, W., Römer, W., Sattler, D., Werner, M., Dose, J., Jänicke, F., Graeff, H., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1689 · Cited by 522
Avril, N. E., Menzel, M. M., Dose, J., Schelling, M., Weber, W., Jänicke, F., NATHRATH, W. B. J., & Schwaiger, M. (2001) · PubMed · Cited by 414
Metabolic Flare: Indicator of Hormone Responsiveness in Advanced Breast Cancer
Mortimer, J. E., Dehdashti, F., Siegel, B. A., Trinkaus, K., Katzenellenbogen, J. A., & Welch, M. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2797 · Cited by 410
Smith, I. C., Welch, A. E., Hutcheon, A. W., Miller, I. D., Payne, S., Chilcott, F., Waikar, S., Whitaker, T., Ah-See, A. K., Eremin, O., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1676 · Cited by 406
Groheux, D., Giacchetti, S., Moretti, J.-L., Porcher, R., Espié, M., Lehmann-Che, J., de Roquancourt, A., Hamy, A.-S., Cuvier, C., Vercellino, L., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1640-9 · Cited by 394
Self-citationBlodgett, T. M., Meltzer, C. C., & Townsend, D. W. (2007) · Radiology · doi:10.1148/radiol.2422051113 · Cited by 387
Wahl, R. L., Siegel, B. A., Coleman, R. E., & Gatsonis, C. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.148 · Cited by 345
FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters
Buck, A., Schirrmeister, H., Kühn, T., Shen, C., Kalker, T., Kotzerke, J., Dankerl, A., Glatting, G., Reske, S., & Mattfeldt, T. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0880-8 · Cited by 305
Loo, C. E., Straver, M. E., Rodenhuis, S., Muller, S. H., Wesseling, J., Vrancken Peeters, M.-J. T. F. D., & Gilhuijs, K. G. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.1258 · Cited by 304
Dehdashti, F., Flanagan, F. L., Mortimer, J. E., Katzenellenbogen, J. A., Welch, M. J., & Siegel, B. A. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050359 · Cited by 290
Dual-Modality Imaging: Combining Anatomy and Function
Townsend, D. W. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.051276 · Cited by 282
Fuster, D., Duch, J., Paredes, P., Velasco, M., Muñoz, M., Santamaría, G., Fontanillas, M., & Pons, F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1496 · Cited by 280
Basu, S., Chen, W., Tchou, J., Mavi, A., Cermik, T., Czerniecki, B., Schnall, M., & Alavi, A. (2008) · Cancer · doi:10.1002/cncr.23226 · Cited by 248
Ueda, S., Tsuda, H., Asakawa, H., Shigekawa, T., Fukatsu, K., Kondo, N., Yamamoto, M., Hama, Y., Tamura, K., Ishida, J., et al. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn019 · Cited by 233
Oshida, M., Uno, K., Suzuki, M., Nagashima, T., Hashimoto, H., Yagata, H., Shishikura, T., Imazeki, K., & Nakajima, N. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980601)82:11<2227::aid-cncr18>3.0.co;2-w · Cited by 230
Schwarz, J., Bader, M., Jenicke, L., Hemminger, G., Jänicke, F., & Avril, N. E. (2005) · PubMed · Cited by 227
Clinicopathologic factors associated with false negative FDG–PET in primary breast cancer
Kumar, R., Chauhan, A., Zhuang, H., Chandra, P., Schnall, M., & Alavi, A. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9159-2 · Cited by 226
Dehdashti, F., Mortimer, J. E., Trinkaus, K., Naughton, M. J., Ellis, M., Katzenellenbogen, J. A., Welch, M. J., & Siegel, B. A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9953-0 · Cited by 213
Schwarz-Dose, J., Untch, M., Tiling, R., Sassen, S., Mahner, S., Kahlert, S., Harbeck, N., Lebeau, A., Brenner, W., Schwaiger, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2650 · Cited by 211
[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy
Berriolo-Riedinger, A., Touzery, C., Riedinger, J.-M., Toubeau, M., Coudert, B., Arnould, L., Boichot, C., Cochet, A., Fumoleau, P., & Brunotte, F. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0459-5 · Cited by 180
Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer
Gil-Rendo, A., Martínez-Regueira, F., Zornoza, G., García-Velloso, M. J., Beorlegui, C., & Rodriguez-Spiteri, N. (2009) · British Journal of Surgery · doi:10.1002/bjs.6459 · Cited by 173
Du, Y., Cullum, I., Illidge, T., & Ell, P. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.2854 · Cited by 171
FDG-PET and Beyond: Molecular Breast Cancer Imaging
Quon, A., & Gambhir, S. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.024 · Cited by 159
Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients
Heusner, T. A., Küemmel, S., Hahn, S., Koeninger, A., Otterbach, F., Hamami, M., Kimmig, K. R., Forsting, M., Bockisch, A., Antoch, G., et al. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1145-6 · Cited by 145
Heusner, T.-A., Küemmel, S., Koeninger, A., Hamami, M., Hahn, S., Quinsten, A. S., Bockisch, A., Forsting, M., Lauenstein, T. C., Antoch, G., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1399-z · Cited by 140
Pennant, M. E., Takwoingi, Y., Pennant, L., Davenport, C. F., Fry-Smith, A., Eisinga, A., Andronis, L., Arvanitis, T. N., Deeks, J. J., & Hyde, C. (2010) · Health Technology Assessment · doi:10.3310/hta14500 · Cited by 135
Cooper, K. L., Harnan, S., Meng, Y., Ward, S. E., Fitzgerald, P., Papaioannou, D. E., Wyld, L., Ingram, C., Wilkinson, I. D., & Lorenz, E. (2011) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.01.003 · Cited by 134
Ueda, S., Tsuda, H., Asakawa, H., Omata, J., Fukatsu, K., Kondo, N., Kondo, T., Hama, Y., Tamura, K., Ishida, J., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-165 · Cited by 126
Beaulieu, S., Kinahan, P. E., Tseng, J. R., Dunnwald, L. K., Schubert, E. K., Pham, P., Lewellen, B., & Mankoff, D. A. (2003) · PubMed · Cited by 124
Effect of 18F-FDG PET/CT Imaging in Patients With Clinical Stage II and III Breast Cancer
Groheux, D., Moretti, J., Baillet, G. Y., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.02.056 · Cited by 122
Self-citation18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer
Duch, J., Fuster, D., Muñoz-Mateu, M., Fernández, P. L., Paredes, P., Fontanillas, M., Guzmán, F., Rubí, S., Lomeña, F. J., & Pons, F. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1116-y · Cited by 121
Cooper, K. L., Meng, Y., Harnan, S., Ward, S. E., Fitzgerald, P., Papaioannou, D. E., Wyld, L., Ingram, C., Wilkinson, I. D., & Lorenz, E. (2011) · Health Technology Assessment · doi:10.3310/hta15040 · Cited by 118
Nakajo, M., Nakajo, M., Kajiya, Y., Kaneko, Y., Kaneko, Y., Takasaki, T., Tani, A., Ueno, M., Koriyama, C., Nakajo, M., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1529-7 · Cited by 115
Fueger, B. J., Weber, W., Quon, A. S. W., Crawford, T. L., Allen-Auerbach, M., Halpern, B. S., Ratib, O. M., Phelps, M. E., & Czernin, J. G. (2005) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0013-4 · Cited by 112
Groheux, D., Hindié, E., Giacchetti, S., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.094045 · Cited by 111
Self-citationDiagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients
Appelbaum, D. (2010) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(10)79570-9 · Cited by 106
Biological characterisation of breast cancer by means of PET
Buck, A. K., Schirrmeister, H., Mattfeldt, T., & Reske, S. N. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1529-6 · Cited by 103
The relationship between FDG uptake in PET scans and biological behavior in breast cancer
Shimoda, W., Hayashi, M., Murakami, K., Oyama, T., & Sunagawa, M. (2007) · Breast Cancer · doi:10.2325/jbcs.14.260 · Cited by 101
Cachin, F., Prince, H., Hogg, A., Ware, R., & Hicks, R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6326 · Cited by 99
Osborne, J. R., Port, E. R., Gönen, M., Doane, A. S., YEUNG, H. W. D., Gerald, W. L., Cook, J., & Larson, S. M. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060459 · Cited by 92
Kumar, A., Kumar, R., Seenu, V., Gupta, S. D., Chawla, M., Malhotra, A., & Mehta, S. N. (2009) · European Radiology · doi:10.1007/s00330-009-1303-z · Cited by 89
Pan, L., Han, Y., Sun, X., Liu, J., & Gang, H. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0746-6 · Cited by 77
Groheux, D., Giacchetti, S., Espié, M., Rubello, D., Moretti, J., & Hindié, E. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1660-5 · Cited by 70
Self-citationVeit‐Haibach, P., Antoch, G., Beyer, T., Stergar, H., Schleucher, R. D., Hauth, E., & Bockisch, A. (2007) · British Journal of Radiology · doi:10.1259/bjr/17395663 · Cited by 66
Martoni, A. A., Zamagni, C., Quercia, S., Rosati, M., Cacciari, N., Bernardi, A., Musto, A., Fanti, S., Santini, D., & Taffurelli, M. (2010) · Cancer · doi:10.1002/cncr.24820 · Cited by 61
Heterogeneity of Metabolic Response to Systemic Therapy in Metastatic Breast Cancer Patients
Huyge, V., Garcia, C., Alexiou, J., et al. (2010) · Clinical Oncology · doi:10.1016/j.clon.2010.05.021 · Cited by 60
Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer
Evangelista, L., Baretta, Z., Vinante, L., Cervino, A. R., Gregianin, M., Ghiotto, C., Saladini, G., & Sotti, G. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1626-7 · Cited by 56
Haug, A. R., Schmidt, G. P., Klingenstein, A., et al. (2007) · Journal of Computer Assisted Tomography · doi:10.1097/01.rct.0000284394.83696.42 · Cited by 51
Grassetto, G., Fornasiero, A., Otello, D., Bonciarelli, G., Rossi, E. G., Nashimben, O., Minicozzi, A. M., Crepaldi, G., Pasini, F., Facci, E., et al. (2010) · European Journal of Radiology · doi:10.1016/j.ejrad.2010.04.029 · Cited by 51
Stahl, A. R., Heusner, T. A., Hartung, V., Nagarajah, J., Bockisch, A., Hahn, S., Antoch, G., & Jentzen, W. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.077461 · Cited by 9
Overexpression of glut-1 glucose transporter in human breast cancer an immunohistochemical study
(1993) · doi:10.1002/1097-0142(19931115)72:10 · Cited by 1
Metadata
- Authors
- Groheux, D., Espié, M., Giacchetti, S., & Hindié, E.
- Venue
- Radiology
- Published
- 2013-02
- Volume
- 266
- Issue
- 2
- Pages
- 388-405
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2135198751
- Cited by
- 271
- References
- 62
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.